HIF Gene Expression in Cancer Therapy
The DOI matches its Crossref record; 115 of the 124 references it cites were found in a registry or an index.
Abstract
Tumor hypoxia is a feature common to almost all solid tumors due to malformed vasculature and inadequate perfusion. Tumor cells have evolved mechanisms that allow them to respond and adapt to a hypoxic microenvironment. The hypoxia-inducible transcription factor (HIF) family is comprised of oxygen-sensitive alpha (alpha) subunits that respond rapidly to decreased oxygen levels and oxygen-insensitive beta (beta) subunits. HIF binds to specific recognition sequences in the genome and increases the transcription of genes involved in a variety of metabolic and enzymatic pathways that are necessary for cells to respond to an oxygen-poor environment. The critical role of this family of transcriptional regulators in maintaining oxygen homeostasis is supported by multiple regulatory mechanisms that allow the cell to control the levels of HIF as well as its transcriptional activity. This review will focus on how the transcriptional activity of HIF is studied and how it can be exploited for cancer therapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Besides hypoxia, several cytokines, growth factors, oncogenes, and gene mutations can increase the expression and stability of HIF-1α, mostly through activation of the phosphoinositide 3-kinase/Akt, Ras/Raf/mitogen-activated protein kinase, and Smad pathways.9”
From Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice (2010) · cites this paper as [9]
Citations
Cites
1 retracted
Lysyl oxidase is essential for hypoxia-induced metastasis
Erler, J. T., Bennewith, K. L., Nicolau, M., Dornhöfer, N., Kong, C., Le, Q.-T., Chi, J.-T. A., Jeffrey, S. S., & Giaccia, A. J. (2006) · Nature · doi:10.1038/nature04695 · Cited by 1,309
Self-citationRetractedTargeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
Carmeliet, P., Dor, Y., Herbert, J.-M., Fukumura, D., Brusselmans, K., Dewerchin, M., Neeman, M., Bono, F., Abramovitch, R., Maxwell, P., et al. (1998) · Nature · doi:10.1038/28867 · Cited by 2,502
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Cited by
Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
Schipani, E., Maes, C., Carmeliet, G., & Semenza, G. L. (2009) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.090602 · Cited by 406
“cancers contain regions of severe hypoxia, resulting in high levels of HIF-1a that drive tumor progression,((32,35)) and inhibition of HIF-1a has been proposed as a potentially powerful approach.((59)) pVHL is expressed in most tissues and cells.”
BackgroundGenerating specificity and diversity in the transcriptional response to hypoxia
Lendahl, U., Lee, K. L., Yang, H., & Poellinger, L. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2665 · Cited by 330
“Tumour cells shift their metabolism to glycolysis during normoxic conditions, and chronic hypoxia in tumours induces genetic instability, which can be important for the malignant progression of tumour”
BackgroundBedogni, B., & Powell, M. B. (2009) · Pigment Cell & Melanoma Research · doi:10.1111/j.1755-148x.2009.00553.x · Cited by 131
“…frequency, to exert a selective pressure for survival of those cells with lower apoptotic potential, to alter the expression of genes involved in cell cycle regulation and cytokine production, and to impact treatment outcome and patient survival (for review on this topic see Chan et al., 2007).”
BackgroundChio, C. C., Lin, J., Cheng, H. A., Chiu, W., Wang, Y., Wang, J. J., Hsing, C., & Chen, R. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0965-5 · Cited by 119
“Functionally, the allied HIF-1 complex is a transcription factor that can attach to specific recognition sequences in the genome to stimulate transcription of certain genes involved in various metabolic pathways that are necessary for cells in response to an oxygen-poor environment (Chan et al. 2007).”
BackgroundOrigin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Sica, A., Porta, C., Morlacchi, S., Banfi, S., Strauss, L., Rimoldi, M., Totaro, M. G., & Riboldi, E. (2011) · Cancer Microenvironment · doi:10.1007/s12307-011-0091-6 · Cited by 101
“activate a distinct set of genes mediating unique biological functions [138].”
Background
Metadata
- Authors
- Chan, D. A., Krieg, A. J., Turcotte, S., & Giaccia, A. J.
- Affiliations
- Stanford Medicine (US)
- Venue
- Methods in Enzymology
- Publisher
- Elsevier
- Published
- 2007
- Volume
- 435
- Pages
- 323-345
- ISSN
- 0076-6879 (ISSN-L)
- OpenAlex
- W1511503838
- Cited by
- 26
- References
- 124
- Citations by year
- 2023: 1 · 2021: 1 · 2018: 2 · 2017: 3 · 2015: 1 · 2014: 1 · 2012: 2
- FWCI
- 5.90
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Methods in enzymology on CD-ROM/Methods in enzymology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA116685, P01CA067166, CA-082566, CA123823, F32CA123823, CA 67166, P01CA082566, R01CA116685)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Keywords
- hypoxia-inducible factor, tumor hypoxia, transcriptional regulation, oxygen homeostasis, solid tumors, cancer therapy, transcriptional activity
- MeSH terms
- Animals, Genetic Techniques, Humans, Neoplasms, Gene Expression, Mice, Knockout, Mice, Hypoxia-Inducible Factor 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIF Gene Expression in Cancer Therapy. https://app.cochat.ai/papers/10.1016/s0076-6879(07)35016-7
- The paper
- Chan, D. A., Krieg, A. J., Turcotte, S., & Giaccia, A. J. (2007). HIF Gene Expression in Cancer Therapy. Methods in Enzymology. https://doi.org/10.1016/s0076-6879(07)35016-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.